ArticleJournal for immunotherapy of cancer2025

Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion.

Dongli Linghu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.